Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings
- PMID: 21919922
- PMCID: PMC3243763
- DOI: 10.1111/j.1530-0277.2011.01628.x
Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings
Abstract
Background: Stress, alcohol cues, and dysregulated stress responses increase alcohol craving and relapse susceptibility, but few pharmacologic agents are known to decrease stress- and cue-induced alcohol craving and associated stress dysregulation in humans. Here we report findings from a preliminary efficacy study of the alpha-1 receptor antagonist, prazosin, in modulating these relapse-relevant factors in alcohol-dependent individuals.
Methods: Seventeen early abstinent, treatment-seeking alcohol-dependent individuals (12 men and 5 women) were randomly assigned to receive either placebo or 16 mg daily prazosin in a double-blind, placebo-controlled manner over 4 weeks. During week 4, all patients participated in a 3-day laboratory experiment involving 5-minute guided imagery exposure to stress, alcohol cue, and neutral-relaxing/control conditions, 1 exposure per day, on consecutive days in a random, counterbalanced order. Alcohol craving, anxiety, negative emotion, cardiovascular measures, and plasma hypothalamic-pituitary-adrenal (HPA; cortisol, adenocorticotropic hormone) were assessed repeatedly in each session.
Results: The prazosin group (n = 9) versus the placebo group (n = 8) showed significantly lower alcohol craving, anxiety, and negative emotion following stress exposure. The placebo group also showed significantly increased stress- and cue-induced alcohol craving, anxiety, negative emotion, and blood pressure (BP), as well as a blunted HPA response relative to the neutral condition, while the prazosin group showed no such increases in craving, anxiety, negative emotion, and BP, and no blunted HPA response to stress and alcohol cue exposure.
Conclusions: Prazosin appears efficacious in decreasing stress- and cue-induced alcohol craving and may normalize the stress dysregulation associated with early recovery from alcoholism. Further research to assess the efficacy of prazosin in reducing alcohol craving and stress-related relapse risk is warranted.
Copyright © 2011 by the Research Society on Alcoholism.
Conflict of interest statement
Disclosure/Conflict of Interest: The authors declare that they have no competing financial interests pertaining to the aims and results of this study.
Figures
References
-
- Bawaskar HS, Bawaskar PH. Prazosin for vasodilator treatment of acute pulmonary oedema due to scorpion sting. Ann Trop Med Parasitol. 1987;81(6):719–23. - PubMed
-
- Boynton L, Bentley J, Strachan E, Barbato A, Raskind M. Preliminary findings concerning the use of prazosin for the treatment of posttraumatic nightmares in a refugee population. J Psychiatr Pract. 2009;15(6):454–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AA013892/AA/NIAAA NIH HHS/United States
- UL1 RR024139/RR/NCRR NIH HHS/United States
- UL1 RR024925/RR/NCRR NIH HHS/United States
- UL1 DE019586/DE/NIDCR NIH HHS/United States
- R01-AA013892/AA/NIAAA NIH HHS/United States
- UL1-DE019586/DE/NIDCR NIH HHS/United States
- K02 DA017232/DA/NIDA NIH HHS/United States
- PL1-DA024859/DA/NIDA NIH HHS/United States
- PL1 DA024860/DA/NIDA NIH HHS/United States
- PL1 DA024859/DA/NIDA NIH HHS/United States
- PL1-DA024860/DA/NIDA NIH HHS/United States
- 1 UL1 RR024139/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
